{"protocolSection":{"identificationModule":{"nctId":"NCT03812445","orgStudyIdInfo":{"id":"cognitionstroke"},"organization":{"fullName":"Shanghai 10th People's Hospital","class":"OTHER"},"briefTitle":"Cognition and Gut Microbiome Associated Study of Shanghai People With Acute Ischemic Stroke","officialTitle":"The Effect of Probiotics on Cognition and Gut Microbiome Associated Study of Shanghai People With Acute Ischemic Stroke"},"statusModule":{"statusVerifiedDate":"2019-02","overallStatus":"UNKNOWN","lastKnownStatus":"RECRUITING","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2018-06-01","type":"ACTUAL"},"primaryCompletionDateStruct":{"date":"2019-11-30","type":"ESTIMATED"},"completionDateStruct":{"date":"2019-12-30","type":"ESTIMATED"},"studyFirstSubmitDate":"2019-01-03","studyFirstSubmitQcDate":"2019-01-20","studyFirstPostDateStruct":{"date":"2019-01-23","type":"ACTUAL"},"lastUpdateSubmitDate":"2019-02-24","lastUpdatePostDateStruct":{"date":"2019-02-26","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"PRINCIPAL_INVESTIGATOR","investigatorFullName":"Huanlong Qin","investigatorTitle":"DIRECTOR","investigatorAffiliation":"Shanghai 10th People's Hospital"},"leadSponsor":{"name":"Shanghai 10th People's Hospital","class":"OTHER"}},"oversightModule":{"isFdaRegulatedDrug":false,"isFdaRegulatedDevice":false},"descriptionModule":{"briefSummary":"The purpose of this study is to evaluate the effect of probiotics on the gut microbiome of ischemic stroke patients.","detailedDescription":"This study aims to detect the impact of probiotics administration during the process of ischemic stroke treatment and recovery phase. The day of admission and 3months after stroke data will be collected and put into analysis to provide some suggestions on the probiotics use in the clinical for the stroke patients."},"conditionsModule":{"conditions":["Gastrointestinal Microbiome"],"keywords":["Probiotics","Gut microbiota","ischemic stroke"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["NA"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"TREATMENT","maskingInfo":{"masking":"NONE"}},"enrollmentInfo":{"count":60,"type":"ESTIMATED"}},"armsInterventionsModule":{"armGroups":[{"label":"No Intervention","type":"NO_INTERVENTION","description":"the patients in this arm will not receive probiotics."},{"label":"Experimental","type":"EXPERIMENTAL","description":"the patients in this arm will receive probiotics blend of Bifidobacterium longum, Lactobacillus acidophilus for 3 months.","interventionNames":["Dietary Supplement: Probiotics"]}],"interventions":[{"type":"DIETARY_SUPPLEMENT","name":"Probiotics","description":"the patients in this arm will receive probiotics blend of Bifidobacterium longum, Lactobacillus acidophilus,Bifidobacterium lactobacillus,Lactobacillus paracasei,Lactobacillus rhamnosus and Lactobacillus fermentium with does of 8\\*10\\^9 Colony-Forming Units(CFU) \\*2/d for 3 months.","armGroupLabels":["Experimental"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"change from admission on gut microbiome at 3months by genome sequencing","description":"change of the gut microbiome will be calculated at 3months in comparison with admission.","timeFrame":"3months"}],"secondaryOutcomes":[{"measure":"change from admission on cognitive function at 3months by Montreal Cognitive Assessment.","description":"change from admission on cognitive function at 3months by Montreal Cognitive Assessment (MoCA). MoCA's score is from 0 to 30.the score is lower,the cognitive disorder is worse.","timeFrame":"3months"},{"measure":"change from admission on emotion at 3months by Hamilton Depression Scale.","description":"change from admission on emotion at 3months by Hamilton Depression Scale（HAMD） .When HAMD's score is beyond 17,the patient is considered to have minor depression.When HAMD's score is beyond 20,the patient is considered to have medium depression. When HAMD's score is beyond 30,the patient is considered to have severe depression.","timeFrame":"3months"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* patients diagnosed with acute ischemic stroke on the basis of World Health Organization diagnostic criteria1.\n\nthe time from paroxysm to admission ≤2weeks.\n\nExclusion Criteria:\n\n* Imaging diagnoses hemorrhagic stroke Severe depression Severe disturbance of hearing vision and reading Illiteracy Have recognitive disorder before stroke (recorded in medical records) Treated with antibiotics probiotics or prebiotics in1month before admission","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"centralContacts":[{"name":"Yongqiang Liu, postgraduate","role":"CONTACT","phone":"18321785703","email":"3101702346@qq.com"},{"name":"Hao Li, MD","role":"CONTACT","email":"1415701131@qq.com"}],"overallOfficials":[{"name":"Huanlong Qin","affiliation":"Shanghai 10th People's Hospital","role":"STUDY_CHAIR"}],"locations":[{"facility":"Shanghai 10th People's Hospital","status":"RECRUITING","city":"Shanghai","zip":"20072","country":"China","contacts":[{"name":"Yongqiang Liu, postgraduate","role":"CONTACT","phone":"18321785703","email":"3101702346@qq.com"},{"name":"Huanlong Qin, PhD","role":"PRINCIPAL_INVESTIGATOR"}],"geoPoint":{"lat":31.22222,"lon":121.45806}}]}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000083242","term":"Ischemic Stroke"}],"ancestors":[{"id":"D000020521","term":"Stroke"},{"id":"D000002561","term":"Cerebrovascular Disorders"},{"id":"D000001927","term":"Brain Diseases"},{"id":"D000002493","term":"Central Nervous System Diseases"},{"id":"D000009422","term":"Nervous System Diseases"},{"id":"D000014652","term":"Vascular Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M10233","name":"Ischemia","relevance":"LOW"},{"id":"M2401","name":"Ischemic Stroke","asFound":"Ischemic Stroke","relevance":"HIGH"},{"id":"M5500","name":"Cerebrovascular Disorders","relevance":"LOW"},{"id":"M4894","name":"Brain Diseases","relevance":"LOW"},{"id":"M5432","name":"Central Nervous System Diseases","relevance":"LOW"},{"id":"M17090","name":"Vascular Diseases","relevance":"LOW"},{"id":"T170","name":"Acute Graft Versus Host Disease","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"},{"abbrev":"Rare","name":"Rare Diseases"}]},"interventionBrowseModule":{"browseLeaves":[{"id":"M15891","name":"Sulfalene","relevance":"LOW"},{"id":"T355","name":"Acidophilus","relevance":"LOW"},{"id":"T367","name":"Bifidobacterium","relevance":"LOW"}],"browseBranches":[{"abbrev":"Infe","name":"Anti-Infective Agents"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"Ot","name":"Other Dietary Supplements"}]}},"hasResults":false}